1. May 1989 as stated in the data sheet
2. Biomedical applications of ICP-MS;Delves, H.T.;Chem Br,1988
3. Request for reports: Adverse reactions with bismuth subgallate;Morrow, A.W.;Medj Austr,1973
4. Aspects epidemiologiques des encephalopathies apres administration de bismuth par voie oral;Martin-Bouyer, G.; Foulon, B.; Guerbois, H.; Barin, C.;Therapie,1980
5. Difference in relapse rates ofduodenal ulcers after healing with cimetidine or triopotassium dicitrato bismuthate;Martin, D.F.; Hollander, D.; May, S.J.; Ravenscroft, M.M.; Tweedle, D.E.S.; Miller, J.P.;Lancet,1981